Probiotics for Colic—Is the Gut Responsible for Infant Crying After All?

Journal of Pediatrics

Volumn 191, Issue , 2017, Pages 6-8

  Sung, Valerie ^a   Cabana, Michael D ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

gastrointestinal microbiome; infant colic; Lactobacillus reuteri

Indexed keywords

CALGRANULIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; PROBIOTIC AGENT;

CELIAC DISEASE; COLIC; COMPARATIVE STUDY; CRYING; CYSTIC FIBROSIS; EDITORIAL; HELICOBACTER PYLORI; HUMAN; INFANT; INFANT DISEASE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS REUTERI; MILK ALLERGY; NECROTIZING ENTEROCOLITIS; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; DOUBLE BLIND PROCEDURE;

COLIC; CRYING; DOUBLE-BLIND METHOD; HUMANS; INFANT; LACTOBACILLUS REUTERI; PROBIOTICS;

EID: 85033671867     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.09.010     Document Type: Editorial

References (37)

1. Fatheree, N.Y., Liu, Y., Taylor, C.M., Hoang, T.K., Cai, C., Rahbar, M.H., et al. Lactobacillus reuteri for infants with colic: a double-blind, placebo-controlled, randomized clinical trial. J Pediatr 191 (2017), 170–178.
2. Akbarian-Rad, Z., Zahedpasha, Y., Ahmadpour-Kacho, M., Rajabnia, R., Tohidi, F., Ferdosi-Shahandashti, E., Intestinal Lactobacillus species: is it equal in colicky and non-colicky breastfed infants?. Iran J Neonatology 4 (2013), 1–4.
3. de Weerth, C., Fuentes, S., Puylaert, P., de Vos, W.M., Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 131 (2013), e550–8.
4. Savino, F., Bailo, E., Oggero, R., Tullio, V., Roana, J., Carlone, N., et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol 16 (2005), 72–75.
5. Savino, F., Cresi, F., Pautasso, S., Palumeri, E., Tullio, V., Roana, J., et al. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 93 (2004), 825–829.
6. Mentula, S., Tuure, T., Koskenala, R., Korpela, R., Kononen, E., Microbial composition and fecal fermentation end products from colicky infants—a probiotic supplementation pilot. Microb Ecol Health Dis 20 (2008), 37–47.
7. Rhoads, J.M., Fatheree, N.Y., Norori, J., Liu, Y., Lucke, J.F., Tyson, J.E., et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr 155 (2009), 823–828 e821.
8. Savino, F., Cordisco, L., Tarasco, V., Locatelli, E., Di Gioia, D., Oggero, R., et al. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol, 11, 2011, 157.
9. Savino, F., Cordisco, L., Tarasco, V., Calabrese, R., Palumeri, E., Matteuzzi, D., Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr 98 (2009), 1582–1588.
10. Partty, A., Kalliomaki, M., Endo, A., Salminen, S., Isolauri, E., Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS ONE, 7, 2012 e32495.
11. Partty, A., Lehtonen, L., Kalliomaki, M., Salminen, S., Isolauri, E., Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial. Pediatr Res 78 (2015), 470–475.
12. Ali, A.M., Helicobacter pylori and infantile colic. Arch Pediatr Adolesc Med 166 (2012), 648–650.
13. Ali, A.S.A., Borei, M.B.M., Helicobacter pylori and Egyptian infantile colic. J Egypt Soc Parasitol 43 (2013), 327–332.
14. Lehtonen, L., Korvenranta, H., Eerola, E., Intestinal microflora in colicky and noncolicky infants: bacterial cultures and gas-liquid chromatography. J Pediatr Gastroenterol Nutr 19 (1994), 310–314.
15. Konikoff, M.R., Denson, L.A., Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006), 524–534.
16. Kostakis, I.D., Cholidou, K.G., Vaiopoulos, A.G., Vlachos, I.S., Perrea, D., Vaos, G., Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review. Dig Dis Sci 58 (2013), 309–319.
17. Vaos, G., Kostakis, I.D., Zavras, N., Chatzemichael, A., The role of calprotectin in pediatric disease. Biomed Res Int, 2013, 2013, 542363.
18. Baldassarre, M.E., Laforgia, N., Fanelli, M., Laneve, A., Grosso, R., Lifschitz, C., Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J Pediatr 156 (2010), 397–401.
19. Olafsdottir, E., Aksnes, L., Fluge, G., Berstad, A., Fecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 91 (2002), 45–50.
20. Partty, A., Kalliomaki, M., Salminen, S., Isolauri, E., Infant colic is associated with low-grade systemic inflammation. J Pediatr Gastroenterol Nutr 64 (2017), 691–695.
21. Chau, K., Lau, E., Greenberg, S., Jacobson, S., Yazdani-Brojeni, P., Verma, N., et al. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 166 (2015), 74–78.
22. Savino, F., Cordisco, L., Tarasco, V., Palumeri, E., Calabrese, R., Oggero, R., et al. Lactobacillus reuteri DSM 17 938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126 (2010), e526–33.
23. Szajewska, H., Gyrczuk, E., Horvath, A., Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162 (2013), 257–262.
24. Mi, G.L., Zhao, L., Qiao, D.D., Kang, W.Q., Tang, M.Q., Xu, J.K., Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek 107 (2015), 1547–1553.
25. Ashraf, M.W., Ayaz, S.B., Ashraf, M.N., Matee, S., Shoaib, M., Probiotics are effective in alleviating infantile colic; results of a randomized controlled trial held at Benazir Bhutto hospital, Rawalpindi, Pakistan. Rawal Med J 40 (2015), 277–280.
26. Sung, V., Hiscock, H., Tang, M.L.K., Mensah, F.K., Nation, M.L., Satzke, C., et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ, 348, 2014, g2107.
27. Savino, F., Castagno, E., Calabrese, R., Viola, S., Oggero, R., Miniero, R., High fecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology 97 (2010), 299–304.
28. Campeotto, F., Butel, M.J., Kalach, N., Derrieux, S., Aubert-Jacquin, C., Barbot, L., et al. High fecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 89 (2004), F353–5.
29. Campeotto, F., Baldassarre, M., Butel, M.J., Viallon, V., Nganzali, F., Soulaines, P., et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 48 (2009), 507–510.
30. Rugtveit, J., Fagerhol, M.K., Rugtveit, J., Fagerhol, M.K., Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 34 (2002), 323–324 author reply 324-5.
31. Nissen, A.C., van Gils, C.E., Menheere, P.P., Van den Neucker, A.M., van der Hoeven, M.A., Forget, P.P., Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 38 (2004), 107–108.
32. Roos, S., Dicksved, J., Tarasco, V., Locatelli, E., Ricceri, F., Grandin, U., et al. 454 pyrosequencing analysis on fecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS ONE, 8, 2013 e56710.
33. Moore, D.J., Tao, B.S., Lines, D.R., Hirte, C., Heddle, M.L., Davidson, G.P., Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 143 (2003), 219–223.
34. Jordan, B., Heine, R.G., Meehan, M., Catto-Smith, A.G., Lubitz, L., Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial. J Paediatr Child Health 42 (2006), 49–58.
35. Loots, C., Kritas, S., Van Wijk, M., McCall, L., Peeters, L., Lewindon, P., et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr 59 (2014), 237–243.
36. Orenstein, S.R., Hassall, E., Furmaga-Jablonska, W., Atkinson, S., Raanan, M., Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 154 (2009), 514–520 e514.
37. Gieruszczak-Białek, D., Konarska, Z., Skórka, A., Vandenplas, Y., Szajewska, H., No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials. J Pediatr 166 (2015), 767–770 e763.